Company Name: Xenon Pharmaceuticals Inc.   

Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. The company develops therapeutics designed to treat rare diseases and has collaborations with several pharmaceutical companies.  The company’s Glybera® is a gene therapy designed to treat lipoprotein lipase deficiency (LPLD) and has been approved in the European Union. The company’s pipeline includes treatment candidates for a variety of conditions including postherpetic neuralgia, dermatological disorders, cardiovascular disease, pain and Dravet Syndrome (DS).

Ticker Symbol: XENE (NASDAQ)

Company Website: www.xenon-pharma.com

Social Media:

Xenon Pharmaceuticals Facebook

Xenon Pharmaceuticals LinkedIn

Xenon Pharmaceuticals Twitter

Headquarters: Burnaby, BC Canada